Neose Technologies said it will reduce its staff by 35% in connection with the discontinuation of NE-180 (GlycoPEGylated erythropoietin), its ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.